SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-22-034692
Filing Date
2022-09-26
Accepted
2022-09-26 16:21:40
Documents
2
Group Members
COREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP III, L.P.VENBIO GLOBAL STRATEGIC GP III, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10042257_sc13da.htm SC 13D/A 181116
2 EXHIBIT 99.4 brhc10042257_ex99-4.htm EX-99.4 15193
  Complete submission text file 0001140361-22-034692.txt   198127
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund III, L.P. (Filed by) CIK: 0001739920 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106
Business Address 888 SEVENTH AVE 12TH FLOOR NEW YORK NY 10106 212-651-6380
Elevation Oncology, Inc. (Subject) CIK: 0001783032 (see all company filings)

IRS No.: 841771427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-92657 | Film No.: 221265978
SIC: 2836 Biological Products, (No Diagnostic Substances)